We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Launches Its Own Challenge to Genentech’s Herceptin Patent, Following Celltrion, Mylan
Pfizer Launches Its Own Challenge to Genentech’s Herceptin Patent, Following Celltrion, Mylan
Following two other firms, Pfizer filed its own petitions with the PTO over a Herceptin patent owned by Genentech, as it continues to develop its biosimilar.
